Advise Taking SGLT2 Inhibitors in the Morning...Due to Their Diuretic Effect
Jardiance (jar-DEE-ans, empagliflozin) will be the third SGLT2 inhibitor...after Invokana (canagliflozin) and Forxiga (dapagliflozin).
These "flozins" inhibit sodium-glucose co-transporter 2 (SGLT2) in the kidney...leading to increased glucose excretion in the urine.
They lower A1C by about 0.7 to 1%...lower systolic blood pressure by 3 to 5 mmHg...reduce weight by 2 to 3 kg...and have a low risk of hypoglycemia when used alone.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive